Prefilled Syringes Market
Prefilled Syringes Market - Global Industry Assessment & Forecast
Segments Covered
- By Type Conventional Prefilled Syringes, Safety Prefilled Syringes
- By Material Glass Prefilled Syringes, Plastic Prefilled Syringes
- By Design Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes, Customized Prefilled Syringes
- By Application Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, Others
- By Region North America, Europe, Asia Pacific, Latin America, Middle East & Africa
Snapshot
Base Year: | 2022 |
Forecast Years: | 2023 - 2030 |
Historical Years: | 2017 - 2021 |
Revenue 2022: | USD 5.43 Billion |
Revenue 2030: | USD 10.59 Billion |
Revenue CAGR (2023 - 2030): | 8.70% |
Fastest Growing Region (2023 - 2030) | Asia Pacific |
Largest Region (2022): | Europe |
Customization Offered
- Cross-segment Market Size and Analysis for Mentioned Segments
- Additional Company Profiles (Upto 5 With No Cost)
- Additional Countries (Apart From Mentioned Countries)
- Country/Region-specific Report
- Go To Market Strategy
- Region Specific Market Dynamics
- Region Level Market Share
- Import Export Analysis
- Production Analysis
- Others Request Customization Speak To Analyst
Market Synopsis:
Global Prefilled Syringes Market is valued at USD 5.43 Billion in 2022 and is projected to reach a value of USD 10.59 Billion by 2030 at a CAGR of 8.70% over the forecast period.
The Prefilled Syringes Market is witnessing growth during the forecast period owing to the increasing occurrences of chronic diseases, technological advancement, and the supportive government regulations. Moreover, the increasing adoption of self-injecting parenteral devices is the other prime factor driving the growth of the Prefilled Syringes Market during the forecast period. In addition, the increasing awareness about the benefits of Prefilled Syringes among the healthcare professionals, and patients together with the rising number of biologics and biosimilars in the pharmaceutical market is effectively contributing in the growth of the Prefilled Syringes Market during the forecast period. Furthermore, the rising technological advancements related to the Prefilled Syringes is positively affecting the growth of Prefilled Syringes Market during the forecast period. As the pharmaceutical companies discovers more convenient and innovative drugs delivery systems, the Prefilled Syringes have appeared as one of the fastest growing choices for unit dosage medicine. Whereas, in the Prefilled Syringes industry are predicted to change in double throughout the forecast period. Besides, the strict government regulations, product recalls, and availability of alternative drug-delivery methods are expected to hamper the growth of Prefilled Syringes Market during the forecast period. On the other hand, increasing adoption of wearable drug delivery technologies and growing healthcare infrastructure across developing markets are projected to provide growth opportunities for the Prefilled Syringes Market in the coming future.
Prefilled Syringes Market Size, 2022 To 2030 (USD Billion)
AI (GPT) is here !!! Ask questions about Prefilled Syringes Market
Market Segmentation:
The Prefilled Syringes Market is segmented on the basis of type, material, design, and application. Based on type, the market is segmented as Conventional Prefilled Syringes, and Safety Prefilled Syringes. Based on material, the market is segmented as Glass Prefilled Syringes, and Plastic Prefilled Syringes. Based on design, the market is segmented as Single-Chamber Prefilled Syringes, Dual- Chamber Prefilled Syringes, and Customized Prefilled Syringes. Based on application, the market is segmented as Diabetes, Rheumatoid Arthritis, Anaphylaxis, Cancer, Thrombosis, Ophthalmology, and others.
Report Coverage & Deliverables
- Real-Time Data Updates:
- Competitor Benchmarking
- Market Trends Heatmap
- Custom Research Queries
- Market Sentiment Analysis
- Demographic and Geographic Insights
Get Access Now
Based on Type-
On the basis of type, the market is segmented as Conventional Prefilled Syringes, and Safety Prefilled Syringes. The safety Prefilled Syringes segment is predicted to grow at a highest CAGR during the forecast period. The growth of the segment is mainly attributed to increasing geriatric population globally, accessibility of biological therapies for patients with the chronic conditions, and outsourcing of low-risk medical procedures for the chronic patients improves some of the pressure on hospitals.
Based on Material-
On the basis of material, the market is segmented as Glass Prefilled Syringes, and Plastic Prefilled Syringes. The glass Prefilled Syringes segment is accounted to hold the largest share of the Prefilled Syringes market during the forecast period. The growth of this segment is primarily attributed to prevention of oxygen and water vapor from combining with the drug compounds, seamless integration into pharmaceutical companies, and compatibility with different filling machines, are driving the growth of the segment in the market.
Europe Holds the Largest Market Share in Terms of Revenue
Europe is one of the foremost revenue-generating regions in the Prefilled Syringes Market. The growth of biologics and biosimilars market, rising prevalence of chronic diseases, geographical expansion by key manufacturers, technological advancements, high adoption of self-injection devices, and increasing aging population are the prime factors driving the growth of the Prefilled Syringes market in the Europe during the forecast period.
Asia Pacific is Predicted to be the Fastest Growing Region During the Forecast Period
Asia Pacific is predicted to grow at highest CAGR during the forecast period. The growth of Prefilled Syringes Market in Asia Pacific region is primarily attributed to rise in number of hospitals furnished with innovative instruments, improvement in healthcare infrastructure, rise in healthcare reforms, development of the R&D sector, and technological advancements in the Prefilled Syringes Market during the forecast period.
Competitive Landscape:
The key-players in the Prefilled Syringes Market includes- Becton, Dickinson and Company, Gerresheimer, Schott AG, West Pharmaceutical Services Inc., Baxter International Inc, Ompi, Catalent Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation, Elcam Medical, Ypsomed, Oval Medical Technologies, SHL Medical AG, Terumo.
Segmentation of Prefilled Syringes Market:
Parameter | Details |
---|---|
Segments Covered |
By Type
By Material
By Design
By Application
By Region
|
Regions & Countries Covered |
|
Companies Covered |
|
Report Coverage | Market growth drivers, restraints, opportunities, Porter’s five forces analysis, PEST analysis, value chain analysis, regulatory landscape, technology landscape, patent analysis, market attractiveness analysis by segments and North America, company market share analysis, and COVID-19 impact analysis |
Pricing and purchase options | Avail of customized purchase options to meet your exact research needs. Explore purchase options |
FAQ
Frequently Asked Question
What is the global demand for Prefilled Syringes in terms of revenue?
-
The global Prefilled Syringes valued at USD 5.43 Billion in 2022 and is expected to reach USD 10.59 Billion in 2030 growing at a CAGR of 8.70%.
Which are the prominent players in the market?
-
The prominent players in the market are Becton, Dickinson and Company, Gerresheimer, Schott AG, West Pharmaceutical Services Inc., Baxter International Inc, Ompi, Catalent Inc., Weigao Group, Vetter Pharma International GmbH, Nipro Corporation, Elcam Medical, Ypsomed, Oval Medical Technologies, SHL Medical AG, Terumo.
At what CAGR is the market projected to grow within the forecast period?
-
The market is project to grow at a CAGR of 8.70% between 2023 and 2030.
What are the driving factors fueling the growth of the market.
-
The driving factors of the Prefilled Syringes include
- Rising target disease population
Which region accounted for the largest share in the market?
-
Europe was the leading regional segment of the Prefilled Syringes in 2022.